Cognios Beta Neutral Large Cap Fund’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$550K Sell
1,936
-199
-9% -$58.2K 0.72% 39
2023
Q4
$615K Sell
2,135
-202
-9% -$55K 0.8% 31
2023
Q3
$628K Sell
2,337
-656
-22% -$164K 0.81% 33
2023
Q2
$665K Sell
2,993
-1,164
-28% -$270K 0.77% 64
2023
Q1
$1M Buy
4,157
+263
+7% +$64.6K 0.96% 38
2022
Q4
$1.02M Buy
+3,894
New +$1.04M 0.98% 33

Other funds holding AMGN

Cognios Beta Neutral Large Cap Fund's AMGN Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Amgen (AMGN) stake by 9.3% in Q1 2024, selling an estimated $58.2K and leaving 1,936 shares worth $550K. The position accounts for 0.72% of the portfolio, ranked #39.

Cognios Beta Neutral Large Cap Fund first reported a position in AMGN in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.02M in Q4 2022. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Cognios Beta Neutral Large Cap Fund held 1,936 shares of Amgen worth $550K as of Q1 2024.
  • Cognios Beta Neutral Large Cap Fund sold 199 Amgen shares in Q1 2024, an estimated $58.2K.
  • Amgen made up 0.72% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #39 holding.
  • Cognios Beta Neutral Large Cap Fund first reported a position in Amgen in Q4 2022 and has held it in 6 quarters since.
  • Cognios Beta Neutral Large Cap Fund's Amgen position peaked at $1.02M in Q4 2022.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.